These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 805351)

  • 21. The antibacterial and pharmacological activity of oxolinic acid (Prodoxol).
    Kershaw MJ; Leigh DA
    J Antimicrob Chemother; 1975 Sep; 1(3):311-5. PubMed ID: 810473
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced oxolinic acid crystalluria and nephrolithiasis.
    Daudon M; Reveilland RJ; Laurence C; Guenel J
    Clin Nephrol; 1987 Sep; 28(3):156. PubMed ID: 3311504
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug therapy reviews: oxolinic acid.
    Gleckman R; Alvarez S; Joubert DW; Matthews SJ
    Am J Hosp Pharm; 1979 Aug; 36(8):1077-9. PubMed ID: 384788
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vibramycin in urinary tract infections].
    Oswald K
    Med Klin; 1968 May; 63(20):804-6. PubMed ID: 4974095
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of bacterial sensitivity to neggram from the aspect of its clinical use].
    Chernomordik AB
    Urol Nefrol (Mosk); 1971; 36(5):63-5. PubMed ID: 4946794
    [No Abstract]   [Full Text] [Related]  

  • 26. Pivmecillinam in complicated urinary infections failing to respond to conventional therapy.
    Brumfitt W; Hamilton-Miller JM
    Infection; 1982; 10(3):149-52. PubMed ID: 6286501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxolinic acid.
    Med Lett Drugs Ther; 1976 Jan; 18(1):2-3. PubMed ID: 1244469
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of 3 or 10 days' treatment with nitrofurantoin or cotrimoxazole in urinary infections in children].
    Ruberto U; D'Eufemia P; Chiummariello R; Giardini O
    Pediatr Med Chir; 1984; 6(1):73-5. PubMed ID: 6442413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs in the treatment of urinary tract infections, microbiologic and clinical evaluation of oxolinic acid.
    Graber H; Arr M; Ternovszky E
    Ther Hung; 1974; 22(3):131-4. PubMed ID: 4445981
    [No Abstract]   [Full Text] [Related]  

  • 30. A bacteriologic and urologic evaluation of sulfamoxole.
    Reed ND; Georgi CE; Jarvis WJ; Munger HV; Lewis GE; Sehnert KW
    J Urol; 1970 Sep; 104(3):474-7. PubMed ID: 4918230
    [No Abstract]   [Full Text] [Related]  

  • 31. Variation in bacteriuria with intestinal loop urinary diversions.
    Stewart W; Cass AS; Matsen JM
    J Urol; 1974 Jan; 111(1):117-9. PubMed ID: 4205087
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy ofrary tct infections with Nicene (a quinoline--sulfanilamide preparation)].
    Metz H; Flogaus K
    Munch Med Wochenschr; 1969 Oct; 111(41):2099-102. PubMed ID: 4900861
    [No Abstract]   [Full Text] [Related]  

  • 33. [In vitro activity of 2 quinoline derivatives, oxolinic and piromidic acid].
    Grima P
    Boll Chim Farm; 1979 Jul; 118(7):363-7. PubMed ID: 526354
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gentamicin in pediatrics].
    Careddu P; Rosaschino F
    G Ital Chemioter; 1969; 16(1):233-9. PubMed ID: 4935431
    [No Abstract]   [Full Text] [Related]  

  • 35. Rationale for the use of nonabsorbable antibiotics to treat urinary infections: preliminary clinical report.
    Schwarz H
    South Med J; 1970 Aug; 63(8):930-4. PubMed ID: 4916929
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of absorption, excretion, antibacterial and clinical effect of cephalexin.
    Henning C; Kallings LO; Lidman K; Sterner G
    Scand J Infect Dis; 1970; 2(2):131-8. PubMed ID: 4398634
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.
    Hof H; Juretschke C
    Infection; 2019 Jun; 47(3):493-495. PubMed ID: 30449013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriuria and asymptomatic infection in chronic patients with indwelling urinary catheter: The incidence of ESBL bacteria.
    Albu S; Voidazan S; Bilca D; Badiu M; Truţă A; Ciorea M; Ichim A; Luca D; Moldovan G
    Medicine (Baltimore); 2018 Aug; 97(33):e11796. PubMed ID: 30113467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Oxolinic acid in urinary infections.
    Meers PD
    Lancet; 1974 Sep; 2(7882):721-2. PubMed ID: 4142993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.